£5.33m
vs Apr 2025Active15689618Private limited companyOxford
RE-AIM THERAPEUTICS LTD
Significant control: Asher Maroof (25–50%), Syncona Portfolio Limited (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Re-Aim Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Re-Aim Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
RE-AIM THERAPEUTICS LTD is an active private limited company (company number 15689618) incorporated on 29 April 2024, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2026, showing net assets of £5.33m and cash of £5.12m, with 3 employees on average. Net assets rose 38024% on the prior period (−£14k).
Peer position · net assets
By net assets it sits in the top quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Dr Asher Maroof
- owns 25–50% of shares
- holds 25–50% of voting rights
- Syncona Portfolio Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 29 April 20242 yrs ago
- Next accounts due
- 31 December 2027in 429 days
- Confirmation statement due
- 13 May 2027in 197 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
05
Financials
£5.12m
+18006%vs Apr 2025Not reported
3
+200%vs Apr 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | £5.33m | £5.12m | £312k | £166k | — | — | 3 |
| 30 April 2025 | −£14k | £28k | £34k | — | — | — | 1 |
Current ratio32.67Current assets ÷ creditors within one year
Cash per employee£1.71mCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £5,332,554 at 31 March 2026
- Net assets up 10% or more on the prior period+38024.4% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 32.67
- Cash at bank of £50,000 or moreCash £5,122,556
- Incorporated two to five years agoIncorporated 29 April 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 429 days
- Confirmation statement duein 197 days
- Accounts period endNet assets £5.33m · small accounts
- Accounts period endNet liabilities £14k · small accounts
- Incorporated
08
Similar companies in Oxford
- EXON VENTURES LIMITEDOxford · inc. Apr 2024
- ARAVAX LIMITEDOxford · inc. May 2024
- AMONOVA LIMITEDOxford · inc. May 2024
- ICOSPHERE BIOSCIENCES LTDOxford · inc. Apr 2024
- LIFE RESEARCH OXFORD LIMITEDOxford · inc. May 2024
- SIGENEX OXFORD LTDOxford · inc. May 2024
All companies incorporated on 29 April 2024 · in Apr 2024.
09
Reminders for RE-AIM THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.